Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bolla

Showing results (221-230 of 237) with videos related to

Pageof 24
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1997
Age is not a limiting factor for radical radiotherapy in pelvic malignanciesT Pignon, J C Horiot, M Bolla, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2012
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapyT Van der Kwast, N Al Daoud, L Collette, et al.
The Journal of Headache and Pain|May 29, 2015
Cost of Chronic and Episodic Migraine. A pilot study from a tertiary headache centre in northern ItalyE Berra, G Sances, R De Icco, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2009
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991O Matzinger, F Duclos, A van den Bergh, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2009
[French radiotherapy database: results of a survey of French radiation oncology centers in 2007]B Chauvet, M Bolla, A Alies-Patin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1997
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialJ C Horiot, P Bontemps, W van den Bogaert, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology groupY Belkacemi, I Latorzeff, A Hasbini, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice]J C Horiot, P Bontemps, A C Begg, et al.
American Journal of Respiratory and Critical Care Medicine|February 24, 2001
Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independentM R Accomazzo, G E Rovati, T Viganò, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 2, 2008
The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trialP M Poortmans, L Collette, H Bartelink, et al.
Pageof 24

Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1997
Age is not a limiting factor for radical radiotherapy in pelvic malignanciesT Pignon, J C Horiot, M Bolla, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2012
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapyT Van der Kwast, N Al Daoud, L Collette, et al.
The Journal of Headache and Pain|May 29, 2015
Cost of Chronic and Episodic Migraine. A pilot study from a tertiary headache centre in northern ItalyE Berra, G Sances, R De Icco, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2009
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991O Matzinger, F Duclos, A van den Bergh, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2009
[French radiotherapy database: results of a survey of French radiation oncology centers in 2007]B Chauvet, M Bolla, A Alies-Patin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1997
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialJ C Horiot, P Bontemps, W van den Bogaert, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology groupY Belkacemi, I Latorzeff, A Hasbini, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice]J C Horiot, P Bontemps, A C Begg, et al.
American Journal of Respiratory and Critical Care Medicine|February 24, 2001
Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independentM R Accomazzo, G E Rovati, T Viganò, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 2, 2008
The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trialP M Poortmans, L Collette, H Bartelink, et al.
Pageof 24